Company Position Nationality
Gouvernement écossais Responsable Efficacité Prescription et Traitement Royaume-Uni
Le digital au service de la prévention : quels modèles de prise en charge proactive envisagés pour retarder l’apparition de la fragilité chez les personnes âgées ?

Alpana is Head of Prescribing and Therapeutics for Scottish Government, coordinating delivery of Governments work programme, and advising Ministers on Quality, safety and effectiveness  of Prescribing. She is responsible for  development of  National Polypharmacy clinical guidance, patient app and shared decision making tools. Alpana has recently been awarded EU funding for implementation of polypharmacy programme across three countries, iSIMPATHY & led successful delivery of European funded project SIMPATHY (Simulating Innovation in the Management of Polypharmacy and Adherence in the elderly), leads work for  WHO on Polypharmacy and is an expert adviser and consultant for the WHO third Global Patient Safety Challenge. For the International Foundation of Integrated Care (IFIC), she coordinates  the Special Interest Group on Appropriate polypharmacy & Adherence and is  EU coordinator for work on Active and Healthy Aging on polypharmacy and medications adherence. As a Quality and Safety fellow, she runs clinics and has received funding to develop a street outreach to improve homeless people’s management of multiple morbidities and medications with third sector partners. Alpana holds a clinical Masters in Clinical Pharmacy and Advanced Leadership Practice from Harvard/ Napier University. She is Senior lecturer in Prescribing at School of Health and Social Care, Napier University, Robert Gordon University and an honorary lecturer at Strathclyde University. She was previously  Deputy Chief Pharmaceutical Officer for Scotland.